Protalix BioTherapeutics (PLX) EBITDA Margin (2009 - 2026)
Protalix BioTherapeutics (PLX) recorded EBITDA Margin of 24.15% in Q2 2026, up 15.91 percentage points from 8.23% a year earlier but down 39.71 percentage points from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) EBITDA Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Protalix BioTherapeutics' EBITDA Margin came in at 30.50% as of Jun 30, 2026, up 15.40 percentage points year-over-year; for FY2025, it was -7.65%, down 17.43 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of -14.03 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 9.78% in FY2024 (-8.01 pp), 17.79% in FY2023 (+42.80 pp), -25.01% in FY2022 (+25.43 pp) and -50.44% in FY2021 (-56.82 pp).
- Quarterly EBITDA Margin has ranged from -120.97% in Q1 2024 to 63.85% in Q1 2026 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in six of the last eight quarters, with an average year-over-year change of +32.21 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 119.10 percentage points in Q2 2023, against a drop of 98.24 percentage points in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 63.85% (Q1 2026), -46.82% (Q4 2025) and 14.02% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Protalix BioTherapeutics | 230.43 Mn | 59.88 Mn | 14.05 Mn | 20.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 20.38% |
| Jun 30, 2026 | 24.15% |
| Mar 31, 2026 | 63.85% |
| Dec 31, 2025 | -46.82% |
| Sep 30, 2025 | 14.02% |
| Jun 30, 2025 | 8.23% |
| Mar 31, 2025 | -37.57% |
| Dec 31, 2024 | 41.40% |
| Sep 30, 2024 | 24.05% |
| Jun 30, 2024 | -15.64% |
| Mar 31, 2024 | -120.97% |
| Dec 31, 2023 | -50.00% |
| Sep 30, 2023 | -14.71% |
| Jun 30, 2023 | 59.25% |
| Mar 31, 2023 | -21.89% |
| Dec 31, 2022 | -24.72% |
| Sep 30, 2022 | -19.56% |
| Jun 30, 2022 | -59.24% |
| Mar 31, 2022 | -9.48% |
| Dec 31, 2021 | -62.50% |
API Access
Protalix BioTherapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();